Next 10 |
home / stock / ipci:cc / ipci:cc news
TORONTO, ON / ACCESSWIRE / March 13, 2024 / Intellipharmaceutics International Inc. (OTCQB:IPCIF)(TSX:IPCI) - (" Intellipharmaceutics " or the " Company "), a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled-release and targeted-rel...
Canadian Investment Regulatory Organization Trading Halt - IPCI Canada NewsWire TORONTO , March 6, 2024 /CNW/ - The following issues have been halted by CIRO: Company: IntelliPharmaCeutics International Inc. TSX Symbol: IPCI All Issues: Yes Reason: Ce...
TORONTO, ON / ACCESSWIRE / February 26, 2024 / Intellipharmaceutics International Inc. (OTCQB:IPCIF)(TSX:IPCI) (" Intellipharmaceutics " or the " Company "), a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled-release and targeted-re...
TORONTO, ON / ACCESSWIRE / February 8, 2024 / Intellipharmaceutics International Inc. (OTCQB:IPCIF)(TSX:IPCI) ("Intellipharmaceutics" or the "Company"), a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled-release and targeted-release...
TORONTO, ON / ACCESSWIRE / January 2, 2024 / Intellipharmaceutics International Inc. (OTCQB:IPCIF)(TSX:IPCI) - ("Intellipharmaceutics" or the "Company"), a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled-release and targeted-releas...
TORONTO, ON / ACCESSWIRE / October 16, 2023 / Intellipharmaceutics International Inc. (OTCQB:IPCIF)(TSX:IPCI) ("Intellipharmaceutics" or the "Company"), a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled-release and targeted-relea...
GoldMining Inc. (GOLD:CA) is expected to report $-0.02 for Q3 2023 Small Pharma Inc. (DMT:CA) is expected to report for Q2 2024 IntelliPharmaCeutics International Inc. (IPCI:CA) is expected to report for Q1 2024
IntelliPharmaCeutics International Inc. (IPCI:CA) is expected to report for Q1 2024
TORONTO, ON / ACCESSWIRE / July 14, 2023 / Intellipharmaceutics International Inc. (OTCQB:IPCIF and TSX:IPCI) ("Intellipharmaceutics" or the "Company"), a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled-release and targeted-release...
Canadian Investment Regulatory Organization Trade Resumption - IPCI Canada NewsWire TORONTO , June 8, 2023 /CNW/ - Trading resumes in: Company: IntelliPharmaCeutics International Inc. TSX Symbol: IPCI All Issues: Yes Resumption (ET): 1...
News, Short Squeeze, Breakout and More Instantly...
Intellipharmaceutics International Inc. Company Name:
IPCI:CC Stock Symbol:
TSXC Market:
TORONTO, ON / ACCESSWIRE / March 13, 2024 / Intellipharmaceutics International Inc. (OTCQB:IPCIF)(TSX:IPCI) - (" Intellipharmaceutics " or the " Company "), a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled-release and targeted-rel...
Canadian Investment Regulatory Organization Trading Halt - IPCI Canada NewsWire TORONTO , March 6, 2024 /CNW/ - The following issues have been halted by CIRO: Company: IntelliPharmaCeutics International Inc. TSX Symbol: IPCI All Issues: Yes Reason: Ce...
TORONTO, ON / ACCESSWIRE / February 26, 2024 / Intellipharmaceutics International Inc. (OTCQB:IPCIF)(TSX:IPCI) (" Intellipharmaceutics " or the " Company "), a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled-release and targeted-re...